January 29, 2025 - 03:52

In a pointed letter to senators deliberating the nomination of Robert F. Kennedy Jr. for the position of health secretary, Caroline Kennedy has expressed her strong disapproval. She described her cousin as a “predator,” accusing him of leading family members into addiction. This unexpected intervention from a member of the Kennedy family has raised eyebrows and intensified the scrutiny surrounding RFK Jr.'s candidacy.
Caroline's remarks highlight deep-seated family tensions and cast a shadow over the nomination process. Her letter emphasizes concerns about Kennedy Jr.’s past actions and their implications for public health leadership. By labeling him a "predator," she not only questions his fitness for the role but also raises alarms about his potential influence on health policies that could affect countless individuals and families.
As senators weigh the merits of his nomination, Caroline Kennedy's stance adds a personal and controversial layer to an already contentious debate, signaling that the Kennedy legacy is not without its internal conflicts.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...